Omalizumab is a medication used to treat moderate to severe allergic asthma and chronic spontaneous urticaria (hives) in individuals who have not responded well to other treatments. It is a monoclonal antibody that works by binding to immunoglobulin E (IgE), a key mediator in allergic reactions.

This page is general information only. It is not a substitute for advice from your doctor or pharmacist.